The aim of the study was to evaluate the clinical performance of FTD SARS-CoV-2 compared to the RealStar RT-PCR kit 1.0. The analysis of 100 nasopharyngeal swabs showed an overall agreement of 88 %. The positive percentage agreement was 85.6 % and the negative percentage agreement was 91 %. In conclusion we observed a substantial agreement among the two methods, with discrepancies mainly observed in specimens with relatively low amount of viral RNA.

中文翻译：

---

FTD SARS-CoV-2 Assay 和 RealStar RT-PCR kit 1.0 检测 SARS-CoV-2 的比较

该研究的目的是评估 FTD SARS-CoV-2 与 RealStar RT-PCR 试剂盒 1.0 相比的临床性能。对 100 份鼻咽拭子的分析表明，总体一致性为 88%。正百分比一致性为 85.6%，负百分比一致性为 91%。总之，我们观察到两种方法之间的基本一致，差异主要在病毒 RNA 量相对较低的样本中观察到。